Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 55

1.

In reply.

Duffner PK, Armstrong FD, Helton K, Brecher ML, Bell B, Chauvenet AR.

J Pediatr Hematol Oncol. 2014 Aug;36(6):501-2. doi: 10.1097/MPH.0000000000000145. No abstract available.

PMID:
24633298
3.

Ewing sarcoma of the mandibular condyle: multidisciplinary management optimizes outcome.

Solomon LW, Frustino JL, Loree TR, Brecher ML, Alberico RA, Sullivan M.

Head Neck. 2008 Mar;30(3):405-10.

PMID:
17657795
4.

Allergy and infectious disease histories and the risk of childhood acute lymphoblastic leukaemia.

Rosenbaum PF, Buck GM, Brecher ML.

Paediatr Perinat Epidemiol. 2005 Mar;19(2):152-64.

PMID:
15787890
5.

Extra copies of chromosome 2 are a recurring aberration in ALK-negative lymphomas with anaplastic morphology.

Kansal R, Sait SN, Block AW, Ward PM, Kelly FL, Cheney RT, Czuczman M, Brecher ML, Barcos M.

Mod Pathol. 2005 Feb;18(2):235-43.

6.

Precursor B lymphoblastic leukemia with surface light chain immunoglobulin restriction: a report of 15 patients.

Kansal R, Deeb G, Barcos M, Wetzler M, Brecher ML, Block AW, Stewart CC.

Am J Clin Pathol. 2004 Apr;121(4):512-25.

7.

Successful lysis of an obstructive aortic and renal artery thrombus in a neonate on extracorporeal membrane oxygenation.

Gunnarsson B, Heard CM, Martin DJ, Brecher ML, Steinhorn RH.

J Perinatol. 2000 Dec;20(8 Pt 1):555-7.

PMID:
11190598
8.

Early child-care and preschool experiences and the risk of childhood acute lymphoblastic leukemia.

Rosenbaum PF, Buck GM, Brecher ML.

Am J Epidemiol. 2000 Dec 15;152(12):1136-44.

9.

Pseudo-rearrangement of the MLL gene at chromosome 11q23: a cautionary note on genotype analysis of leukaemia patients.

Stanulla M, Sch√ľnemann HJ, Thandla S, Brecher ML, Aplan PD.

Mol Pathol. 1998 Apr;51(2):85-9.

10.

A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.

Hill JM, Kornblith AB, Jones D, Freeman A, Holland JF, Glicksman AS, Boyett JM, Lenherr B, Brecher ML, Dubowy R, Kung F, Maurer H, Holland JC.

Cancer. 1998 Jan 1;82(1):208-18.

PMID:
9428499
12.

Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.

Weiner MA, Leventhal B, Brecher ML, Marcus RB, Cantor A, Gieser PW, Ternberg JL, Behm FG, Wharam MD Jr, Chauvenet AR.

J Clin Oncol. 1997 Aug;15(8):2769-79.

PMID:
9256118
13.

Intermediate-dose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: a ten-year follow-up.

Freeman AI, Boyett JM, Glicksman AS, Brecher ML, Leventhal BG, Sinks LF, Holland JF.

Med Pediatr Oncol. 1997 Feb;28(2):98-107.

PMID:
8986145
14.

Clonal evolution in B-lineage acute lymphoblastic leukemia by contemporaneous VH-VH gene replacements and VH-DJH gene rearrangements.

Choi Y, Greenberg SJ, Du TL, Ward PM, Overturf PM, Brecher ML, Ballow M.

Blood. 1996 Mar 15;87(6):2506-12.

15.

Profile of immunoglobulin heavy chain variable gene repertoires and highly selective detection of malignant clonotypes in acute lymphoblastic leukemia.

Greenberg SJ, Choi Y, Ballow M, Du TL, Ward PM, Rickert MH, Frankel S, Bernstein SH, Brecher ML.

J Leukoc Biol. 1995 Jun;57(6):856-64.

16.

Burkitt's lymphoma of the parapharyngeal space.

Bauer GP, Volk MS, Siddiqui SY, Brecher ML, Brodsky LS, Stanievich JF, Jockin H, Kakati S.

Arch Otolaryngol Head Neck Surg. 1993 Jan;119(1):117-20.

PMID:
8417736
17.

Cremophor-EL enhances taxol efficacy in a multi-drug resistant C1300 neuroblastoma cell line.

Chervinsky DS, Brecher ML, Hoelcle MJ.

Anticancer Res. 1993 Jan-Feb;13(1):93-6.

PMID:
8097392
18.

Reversal of C1300 murine neuroblastoma multidrug resistance by cremophorEL, a solvent for cyclosporin A.

Chervinsky DS, Brecher ML, Baker RM, Hoelcle MJ, Tebbi CK.

Cancer Biother. 1993 Spring;8(1):67-75.

PMID:
7812351
19.

Recombinant interferon alfa given before and in combination with standard chemotherapy in children with acute lymphoblastic leukemia in first marrow relapse: a Pediatric Oncology Group pilot study.

Ochs J, Brecher ML, Mahoney D, Vega R, Pollock BH, Buchanan GR, Whitehead VM, Ravindranath Y, Freeman AI.

J Clin Oncol. 1991 May;9(5):777-82.

PMID:
2016619
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk